Back to News
Market Impact: 0.15
AI Financial Corporation Rebrands Its Biotech Business as Drew Therapeutics in Honor of Andrew Witkoff, Who Succumbed to Opioid Addiction in 2011
Source: Newswire
Healthcare & BiotechManagement & Governance
The biotech company is rebranding to memorialize the brother of AI Financial Chairman Zach Witkoff. The change also aligns with the company's ongoing research into non-addicting pain treatments; the article gives no financial or clinical results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
AIFC0.10
More News
- WiseTech shares surge as ASIC drops action against founder White
- Lawyer of arrested OpenAI engineer says allegations are ‘wholly out of character,’ one-way ticket to Saudi Arabia with wife and child was pre-booked
- Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make
- Berkshire Hathaway heads for 10th consecutive winning day. What's driving the stock
- 25 years ago, Netflix laid off a third of its employees and learned a lesson about ‘talent density.’ New cuts will test whether it still works
- Lisa Cook lawyer doubts Trump committee's fairness as president calls her 'automatic no vote'
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- How to Build an Automated Research Process for a Fund
- Weekly Update: AI-Powered Report Editing, Investor Relations, and Enhanced Search